Celcuity (CELC) Current Leases (2018 - 2025)

Celcuity (CELC) reported Current Leases of $54000.0 for Q4 2025, down 68.6% on a YoY basis from $172000.0 in Q4 2024, and down 43.75% quarter-over-quarter from $96000.0 in Q3 2025.

Celcuity (CELC) Current Leases (2018 - 2025) Analysis & Trends

Celcuity has reported Current Leases for 8 years, with the latest figure at $54000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Leases fell 68.6% year-over-year to $54000.0; the trailing twelve-month figure through Dec 2025 stood at $54000.0 (down 68.6% YoY), and the FY2025 full-year result was $54000.0, down 68.6% from the prior year.
  • Current Leases for Q4 2025 stood at $54000.0, down from $96000.0 in the prior quarter.
  • The five-year high for Current Leases was $194895.0 in Q1 2023, with the low at $5819.0 in Q1 2021.
  • Historically, Current Leases has averaged $143237.4 across 5 years, with a median of $176906.5 in 2024.
  • Annual changes were most pronounced in 2021 — Current Leases sank 96.7% — and 2022, when it jumped 3232.93%.
  • Celcuity's Current Leases stood at $189858.0 in 2021, then increased by 1.0% to $191749.0 in 2022, then decreased by 3.55% to $184950.0 in 2023, then slipped by 7.0% to $172000.0 in 2024, then slumped by 68.6% to $54000.0 in 2025.
  • The last three Current Leases figures came in at $54000.0 (Q4 2025), $96000.0 (Q3 2025), and $139000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 42,980.09
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 83,991.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 7.40 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Celcuity 4.14 Bn 3.42 Bn - 54,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 54,000.00
Sep 30, 2025 96,000.00
Jun 30, 2025 139,000.00
Mar 31, 2025 169,000.00
Dec 31, 2024 172,000.00
Sep 30, 2024 175,226.00
Jun 30, 2024 178,587.00
Mar 31, 2024 181,882.00
Dec 31, 2023 184,950.00
Sep 30, 2023 188,100.00
Jun 30, 2023 191,333.00
Mar 31, 2023 194,895.00
Dec 31, 2022 191,749.00
Sep 30, 2022 194,643.00
Jun 30, 2022 156,769.00
Mar 31, 2022 189,267.00
Dec 31, 2021 189,858.00
Sep 30, 2021 5,840.00
Jun 30, 2021 5,830.00
Mar 31, 2021 5,819.00